Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch

NCT: NCT06164808 · RECRUITING

NCT IDNCT06164808
StatusRECRUITING
Start Date2024-02-20
Completion2026-12-31

Brief Summary

Heart rhythm disorders are common and significantly impact the lives of those affected and their families. The main problems can be categorized as: a) atrial fibrillation or AF and atrial flutter, b) supra-ventricular tachycardia or SVT, c) excessively slow heart beats (i.e., bradycardia or pauses) and d) ventricular arrhythmias. These problems can be difficult to detect with currently available monitoring options as they are all worn for shorter terms or are an invasive implantable option. The HeartWatch is a longer term monitoring system that is worn on the upper arm, allows users to create a tag and pairs with an app on a smartphone allowing for correlation of symptoms.

Frequently Asked Questions

What is Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch?

Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch is a clinical trial registered under NCT06164808. Current status: RECRUITING.

What is the status of NCT06164808?

The current status of NCT06164808 (Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch) is: RECRUITING.

When did Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch start?

Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch started on 2024-02-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.